|
|
Other links at Articles > Critical Care |
| 3. |
FDA Safety Changes: Advair Diskus and Vfend
|
|
|
The FDA has approved revisions to the safety labeling for fluticasone propionate plus salmeterol xinafoate inhalation powder and voriconazole tablets, injection, and oral suspension. Medscape Medical News
|
|
|